Abstract

We previously reported the elevated expression of circ_0057558 in prostate cancer tissues and cell lines. Here, we aimed to determine the biological function of circ_0057558 in prostate cancer. In the current study, circ_0057558 knockdown in prostate cancer cells significantly repressed cell proliferation and colony formation, but promoted cell arrest and enhanced the sensitivity to docetaxel. Bioinformatics analysis prediction and RNA-pull down assay identified miR-206 as the potential binding miRNA of circ_0057558. A negative correlation was observed between the expression of miR-206 and circ_0057558 in prostate cancer tissues. miR-206 mimics rescued the function of circ_0057558 overexpression on prostate cancer cells. Further, the bioinformatics analysis and luciferase assay suggested that miR-206 may target ubiquitin-specific peptidase 33 (USP33). USP33 mRNA expression has negative correlation with miR-206 expression and positive correlation with circ_0057558 expression in prostate cancer tissues. USP33 overexpression partially blocked the effects of miR-206 mimics on prostate cell proliferation. USP33 could bind and deubiquitinate c-Myc. Increased c-Myc protein by circ_0057558 overexpression was partially reversed by miR-206 mimics. The proliferation inhibition activity of MYC inhibitor 361 (MYCi361) was more prominent in primary prostate cancer cells and patient-derived xenograft (PDX) model with higher level of circ_0057558. Collectively, circ_0057558 gives an impetus to cell proliferation and cell cycle control in prostate cancer cell lines by sponging miR-206 and positively regulating the transcription of the miR-206 target gene USP33.

Highlights

  • Prostate cancer is one of the most frequent malignancies in men, causing high morbidity and mortality (Siegel et al, 2016)

  • The findings proved that ubiquitin-specific peptidase 33 (USP33) was a direct target gene of miR-206 in prostate cancer

  • The relative luciferase activity normalized to the control group. ***P < 0.001 versus miR-NC. (D) quantitative real-time polymerase chain reaction (qRT-PCR) analysis following the RIP assay was conducted to confirm the interaction between miR-206 with USP33. $$$P < 0.001 versus IgG. (E) Expression of USP33 mRNA in prostate cancer tissue and adjacent non-tumor tissue. (F,G) Pearson r analysis showed the correlation between the expression of miR-206 and USP33 and the expression of circ_0057558 and USP33 in prostate cancer tissues

Read more

Summary

Introduction

Prostate cancer is one of the most frequent malignancies in men, causing high morbidity and mortality (Siegel et al, 2016). Prostate-specific antigen (PSA) testing is the standard screening marker for prostate cancer diagnosis. Because of the poor specificity of PSA screening, it contributes to overdiagnosis and subsequent overtreatment (Tarhan et al, 2005; De Nunzio et al, 2011). Docetaxel represents the most active chemotherapeutic agent for circ_0057558 and Prostate Carcinogenesis prostate cancer. Inherent or acquired drug resistance limits the efficacy of docetaxel (O’Neill et al, 2011). It is urgent to identify novel diagnostic and prognostic biomarkers for prostate cancer and improve our understanding of the molecular basis of prostate cancer

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call